<DOC>
	<DOCNO>NCT02907606</DOCNO>
	<brief_summary>This study evaluate feasibility effectiveness urinary ctDNA detection dynamic monitoring treatment NSCLC patient prospectively , collect detect tumor tissue , peripheral blood sample urine sample NSCLC patient .</brief_summary>
	<brief_title>Urinary Circulating Tumor DNA Detection Non-small Cell Lung Cancer : Prospective Study</brief_title>
	<detailed_description>Liquid biopsy , specifically assessment circulate tumor DNA ( ctDNA ) peripheral blood , show great promise lung cancer diagnosis therapeutic monitoring . Urinary sample completely non-invasive easily obtainable compare blood tissue extraction . To date , limited number publish study examine feasibility ctDNA detection urine . This study collect tumor tissue , pretreatment peripheral blood sample urine sample different TNM stage NSCLC patient , detect EGFR gene mutation pair sample .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>Aged 18 80 year Histologically confirm diagnosis stage nonsmall cell lung cancer undergo surgical resection Completed explicit information TNM staging Paired specimens include tumor tissue , peripheral blood sample urinary sample surgery . Patients must give write informed consent Unable comply study procedure Malignant tumor history within past 5 year Coexisting small cell lung cancer Unqualified tissue , blood urine sample</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>Non-small-cell Lung Cancer</keyword>
	<keyword>circulate tumor DNA</keyword>
	<keyword>urine</keyword>
</DOC>